11 - 13 September 2017 | London, UK

Conference Day 2

8:30 am - 8:55 am Registration and Coffee

8:55 am - 9:00 am Chairman's Opening Address

9:00 am - 9:40 am Case Study: Setting the Standard for Plasmid DNA Production

  • Hear about a ready to use platform for fast track pDNA supply
  • Examine the different scale up of pDNA manufacturing technologies
  • Learn about the production of antibiotic resistance free plasmids 

9:40 am - 10:20 am Cost Efficiency For Allogenic Production

  • Highlight what strategic points need to be considered when addressing the challenges that arise with increasing production
  • Examine how to implement scalable and standardised manufacturing methods
  • Determine what regulatory aspects need to be considered when strategising towards increasing production

10:20 am - 10:50 am Coffee Break

10:50 am - 11:30 am Utilizing Closed System Processing For Cell Therapy Manufacturing

  • Decipher what challenges will arise when implementing a closed system process
  • Hear a case study on how the adoption of closed systems across cell therapy manufacturing processes improved QA
  • Design protocols to transition from open to closed-system manufacturing

11:30 am - 12:10 pm Roundtable Discussions

Choose from 6 different round table discussions to participate in, each facilitated by a leading industry figure

Roundtable 1: Effective advanced therapy production
Roundtable 2: Choosing the right starting material for cell and gene production
Roundtable 3: Identifying risk based strategy for commercialising cell and gene therapies
Roundtable 4: Determining the scale up opportunities for allogenic therapy production
Roundtable 5: How will patient view and accessibility improve cost of autologous production
Roundtable 6: Research Development for Cellular Therapy Production

12:10 pm - 1:10 pm Lunch

1:10 pm - 1:50 pm Case Study: Optimising Manufacturing Opportunities For Allogenic Production

  • Learn how to prevent cross contamination of allogenic products in manufacturing
  • Scrutinise how to achieve high level efficiency in producing “off the shelf” industrial product
  • Hear the latest initiatives in overcoming challenges faced with multiple product manufacturing

1:50 pm - 2:30 pm Case Study: Plasmid and Vector Manufacturing Techniques

  • Hear how vectors, including adenovirus, adeno-associated virus and lenti virus, can be safely generated
  • Determine how to design viral vectors for medicinal products
  • Plan your production around issues and considerations needed to be addressed before establishing a GMP compliant gene therapy protocol

2:30 pm - 3:00 pm Coffee Break

3:30 pm - 4:10 pm The Logistics of Advanced Therapy Manufacturing

  • Choose the right approach for building a successful logistics strategy
  • Compare the difference between autologous and allogenic logistic requirements
  • Anticipate what potential challenges can arise throughout the supply chain

4:10 pm - 4:50 pm Case study: How To Enhance Manufacturing Processes With The Move Between Open and Closed Manufacturing

4:50 pm - 5:00 pm Chairman's Closing Address